Doxycycline Hyclate Solicitation
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-R-0004
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support has issued an active solicitation, identified as SPE2D2-25-R-0004, for the procurement of Doxycycline Hyclate. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further designated by Product Service Code 6505, indicating a focus on drugs and biologicals.
The primary objective of this procurement is to secure a reliable supply of Doxycycline Hyclate, a pharmaceutical product essential for troop support and medical readiness. The solicitation aims to identify qualified manufacturers or suppliers capable of meeting the agency’s requirements for quality, compliance, and timely delivery. The scope of the contract encompasses the manufacturing and provision of Doxycycline Hyclate in accordance with federal standards and specifications, ensuring the product’s suitability for use within the intended operational context.
Amendment 0004 to the solicitation has been issued to address a procedural oversight in Amendment 0003, specifically clarifying that offerors are not required to provide a signature to acknowledge the change in solicitation language introduced by the previous amendment. All other terms and conditions of the solicitation remain unchanged, maintaining consistency in the requirements and expectations set forth by DLA Troop Support.
Interested contractors should note that the solicitation is managed by the DLA Troop Support office, a federal entity responsible for the procurement of medical supplies and pharmaceuticals for military and related federal operations. The primary point of contact for this opportunity is Courtney Hunter-Stangler, who can be reached at [email protected] or by phone at 215-737-6845. A secondary contact, Jason C. Wray, is also available at [email protected] or 215-737-0614, providing additional support for inquiries related to the solicitation.
The notice was posted on March 2, 2025, with a response deadline set for May 2, 2025, allowing prospective offerors ample time to review the solicitation documents and submit their proposals. The solicitation and related attachments are accessible via the official SAM.gov portal at https://sam.gov/opp/c5f422c9381c4c92854f5bc2758a3bb5/view, where six supporting documents are available for review.
This procurement represents a significant opportunity for contractors specializing in pharmaceutical manufacturing, particularly those with experience in producing Doxycycline Hyclate or similar products for federal agencies. The requirements and deliverables are expected to remain consistent throughout the contract lifecycle, focusing on quality assurance, regulatory compliance, and reliable supply chain management. Contractors are encouraged to review all solicitation materials and amendments carefully to ensure alignment with the agency’s needs and to prepare comprehensive proposals that address all stated requirements.
Documents6